Abstract | BACKGROUND: OBJECTIVE: The purpose of this study was to investigate the effect of suplatast on antigen-induced airway cough hypersensitivity and eosinophil infiltration into the airway. METHODS: Number of coughs elicited by inhalation of increasing concentrations of capsaicin (10-8, 10-6 and 10-4 M) was counted 24 h after an antigen challenge in conscious guinea-pigs and then bronchoalveolar lavage was performed. We investigated the effect of single (before antigen challenge or capsaicin provocation) or repetitive treatment with intraperitoneal suplatast at a dose of 10 or 30 mg/kg on antigen-induced cough hypersensitivity. RESULTS: Twenty-four hours after antigen challenge, guinea-pigs developed an increase in cough receptor sensitivity to inhaled capsaicin and eosinophil infiltration in the airways. After a 2-week treatment with suplatast, but not after only a single treatment before antigen challenge or capsaicin provocation, the antigen-induced early phase bronchoconstriction, cough hypersensitivity, and airway eosinophilia were inhibited in a dose-dependent manner. CONCLUSION:
|
Authors | S Myou, M Fujimura, K Kurashima, T Kita, H Tachibana, Y Ishiura, M Abo, S Nakao |
Journal | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
(Clin Exp Allergy)
Vol. 31
Issue 12
Pg. 1939-44
(Dec 2001)
ISSN: 0954-7894 [Print] England |
PMID | 11737047
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Allergic Agents
- Arylsulfonates
- Sulfonium Compounds
- Ovalbumin
- suplatast tosilate
|
Topics |
- Airway Resistance
(drug effects)
- Animals
- Anti-Allergic Agents
(therapeutic use)
- Arylsulfonates
(therapeutic use)
- Bronchial Provocation Tests
(adverse effects)
- Bronchoalveolar Lavage Fluid
(cytology)
- Bronchoconstriction
(drug effects)
- Cough
(drug therapy)
- Disease Models, Animal
- Eosinophils
(drug effects)
- Guinea Pigs
- Japan
- Male
- Ovalbumin
(adverse effects)
- Respiratory Hypersensitivity
(drug therapy)
- Sensitivity and Specificity
- Sulfonium Compounds
(therapeutic use)
- Time Factors
|